Three drug company executives agree to pay more than $600 million for misleading consumers about Oxycontin's risks, with Mike Huckman, CNBC pharmaceuticals reporter
Topics:
Biotechnology | PharmaceuticalsHealth Care
Sectors:
| Insurance
COMMENTS
Thank you for joining our discussion. Your comment has been posted.
Data is a real-time snapshot *Data is delayed at least 15 minutes Market Data Terms of Service
Global Business and Financial News, Stock Quotes, and Market Data and Analysis
More Comments
ADD COMMENTS
PREVIEW COMMENT